Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage

Gabor E. Linthorst, Alessandro P. Burlina, Franco Cecchi, Timothy M. Cox, Janice M. Fletcher, Ulla Feldt-Rasmussen, Roberto Giugliani, Carla E. M. Hollak, Gunnar Houge, Derralynn Hughes, Iikka Kantola, Robin Lachmann, Monica Lopez, Alberto Ortiz, Rossella Parini, Alberto Rivera, Arndt Rolfs, Uma Ramaswami, Einar Svarstad, Camilla Tondel, Anna Tylki-Szymanska, Bojan Vujkovac, Steven Waldek, Michael West, F. Weidemann, Atul Mehta
  • JIMD Reports, January 2012, Springer Science + Business Media
  • DOI: 10.1007/8904_2012_160

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/8904_2012_160

The following have contributed to this page: Professor Ulla Feldt-Rasmussen and Professor franco cecchi